Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists
MicroRNAs (miRNAs) are small non-coding RNAs involved in the regulation of gene expression. Dysregulated expression of several miRNAs has been found in primary immune thrombocytopenia (ITP) suggesting that miRNAs are likely involved in the pathogenesis of ITP. We aimed to explore the differential ex...
Main Authors: | Lamya Garabet, Waleed Ghanima, Anbjørg Rangberg, Raul Teruel-Montoya, Constantino Martinez, Maria Luisa Lozano, Camilla F. Nystrand, James B. Bussel, Per Morten Sandset, Christine M. Jonassen |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-02-01
|
Series: | Platelets |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09537104.2019.1585527 |
Similar Items
-
Combination of two target agonists of the thrombopoietin and thrombopoietin receptor in the treatment of elderly patients with refractory immune thrombocytopenia
by: Jundong Zhang, et al.
Published: (2023-04-01) -
ASH 2019 guidelines for immune thrombocytopenia: “Old wine in a new bottle with added spices”
by: Ravi M. Shah, et al.
Published: (2021-06-01) -
Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review
by: Simone Birocchi, et al.
Published: (2021-02-01) -
Effect of Thrombopoietin Receptor Agonist on Pregnant Mice
by: Kensaku Nakai, et al.
Published: (2022-02-01) -
Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonists
by: Lamya Garabet, et al.
Published: (2020-04-01)